"Merck"

Search all headlines
Latest News
In the last 6 hours
Summit presents Phase 3 lung cancer data beating Merck's Keytruda ENDPOINTS16:45
Akeso, Summit's PD-1 bispecific crushes Merck's Keytruda in study, signaling potential new… FiercePharma16:42
In the last 7 days
Merck (MRK) Stock Moves -0.63%: What You Should Know Zacks22:07 6-Sept-24
Senator Dr. Rasha Kelej consolidates efforts to address critical social and health issues in… African Press Organization13:50 6-Sept-24
What's Going On With Merck Shares Thursday? Benzinga19:48 5-Sept-24
Merck says it plans to introduce more key materials to boost localization Taipei Times16:47 5-Sept-24
Merck Starts Late-Stage Study on Recently Acquired Ophthalmology Drug Zacks16:36 5-Sept-24
What's Wrong With Merck's Stock? The Motley Fool09:30 5-Sept-24
Merck's Keytruda & Padcev Combo Gets EU Nod for Urothelial Carcinoma Zacks15:00 4-Sept-24
Merck Receives Industry First EXCiPACT Certification for Cell Culture Media ... Merck Group (Press Release)14:41 4-Sept-24
Merck to Present Survival Data and New Research on 10 Investigational or Approved Medicines at… Business Wire (Press Release)11:54 4-Sept-24
Merck and EyeBio Announce Initiation of Phase 2b/3 Clinical Trial for Restoret™ for the… Business Wire (Press Release)11:44 4-Sept-24
EC approves Merck’s KEYTRUDA-Padcev combo for urothelial cancer Pharmaceutical Technology09:50 4-Sept-24
Senator, Dr. Rasha Kelej emphasizes on the Importance of Supporting Girl Education in the… African Press Organization09:43 4-Sept-24
Updating Walmart, Merck And Nike Post-Earnings Seeking Alpha21:28 3-Sept-24
Merck's Death Cross Vs. Gilead's Golden Cross: Pharma Giants Diverge On Wall Street Benzinga21:23 3-Sept-24
Insomnia Drugs Business Research Report 2023-2030 Featuring Astellas Pharma, Eisai, Flynn… Business Wire (Press Release)19:06 3-Sept-24
Amid Major Threats, Merck Stock Is A Sell Seeking Alpha18:28 3-Sept-24
Merck & Co. Stock: Is MRK Underperforming the Healthcare Sector? Barchart08:46 3-Sept-24
Primary Cells Market Industry Report 2024, with Focus on Key Players Allcells, ATCC, Axol Bioscience, Cell Biologics,… GlobeNewswire (Press Release)16:52 2-Sept-24
Merck and Astellas/Pfizer’s bladder cancer combination granted EC approval PMLiVE12:30 2-Sept-24
Merck's Change To Profit Guidance Provides An Opportunity Seeking Alpha19:32 1-Sept-24
In the last month
Behind the Scenes of Merck & Co's Latest Options Trends Benzinga22:47 30-Aug-24
Merck Scraps Two Late-Stage Keytruda Studies on Disappointing Data Zacks17:35 30-Aug-24
Merck opens London lab as it makes push into immunology and the UK ENDPOINTS16:46 30-Aug-24
Senator, Dr. Rasha Kelej focuses on ‘Stopping Child Marriage’ in the Thirteenth Episode of “Our … African Press Organization13:42 30-Aug-24
Merck KGaA doses first subject in Phase III generalised Myasthenia Gravis trial Clinical Trials Arena11:34 30-Aug-24
Merck Discontinues Two More Phase III Keytruda Studies Scrip Pharma Intelligence22:41 29-Aug-24
Merck to Discontinue KEYNOTE-867 and KEYNOTE-630 Trials of Pembrolizumab in NSCLC, CSCC OncLive16:27 29-Aug-24
Merck Pulls Plug On Two Keytruda Late-Stage Studies On Underwhelming Data Benzinga15:38 29-Aug-24
Merck’s Keytruda flunks pivotal studies in early-stage lung and skin cancers FiercePharma15:27 29-Aug-24
Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase III Study of Oral… Business Wire (Press Release)13:37 29-Aug-24
Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized… Business Wire (Press Release)13:37 29-Aug-24
Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in ... Merck Group (Press Release)13:37 29-Aug-24
Merck ends two Phase 3 studies of Keytruda, including an early-stage non-small cell lung cancer trial ENDPOINTS12:46 29-Aug-24
Merck to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference Business Wire (Press Release)11:46 29-Aug-24
Merck Provides Update on Phase 3 KEYNOTE-867 and KEYNOTE-630 Trials Business Wire (Press Release)11:35 29-Aug-24
Merck Must Face Class Claims In Vaccine Antitrust Suit Law36003:58 29-Aug-24
Senator, Dr. Rasha Kelej focuses on ‘Women Empowerment’ in the Twelfth Episode of “Our Africa… African Press Organization14:22 28-Aug-24
Merck’s Winrevair receives EC approval to treat pulmonary arterial hypertension in adults PMLiVE12:30 28-Aug-24
Do Options Traders Know Something About Merck Stock We Don't? Benzinga18:33 27-Aug-24
Redalpine closes $200M fund; A base editing pact in China; Merck starts another Phase 3 for Imago drug ENDPOINTS16:23 27-Aug-24
Senator, Dr. Rasha Kelej focuses on the Importance of Supporting Girl Education in the Eleventh … African Press Organization15:08 27-Aug-24
Merck Stock Worth Watching on PAH Drug Winrevair's Approval in Europe? Zacks14:09 27-Aug-24
IVD Raw Materials Focused Insights Report 2024: A $38+ Bn Market by 2029 Featuring Key Players - Merck, Fujirebio,… GlobeNewswire (Press Release)12:46 27-Aug-24
Merck Announces Phase 3 Trial Initiation for Bomedemstat, an Investigational Candidate for the… Business Wire (Press Release)11:55 27-Aug-24
Premature Ejaculation Treatment Business Research Report 2024 Featuring Absorption Pharma, Allergan, AstraZeneca,… GlobeNewswire (Press Release)10:57 27-Aug-24
Merck gains EC approval for Winrevair to treat patients with pulmonary arterial hypertension Manufacturing Chemist09:23 27-Aug-24
Merck Animal Health Announces The Availability Of Poultry Vaccine For Deadly Virus AgriMarketing08:04 27-Aug-24
Merck’s Winrevair Approved For PAH In Europe As Initial US Launch Progresses Scrip Pharma Intelligence23:32 26-Aug-24
EU clears Regeneron’s Ordspono, Merck’s Winrevair, ARS’ Eurneffy BioWorld21:56 26-Aug-24
European Commission Approves Merck Treatment Combined with Other Therapies for Pulmonary Arterial Hypertension PharmTech.com18:16 26-Aug-24
Cell Counting Devices Market - Global Outlook & Forecast 2024-2029 by Product, Application, End-user and Region… GlobeNewswire (Press Release)14:34 26-Aug-24
Merck Manuals: Clearing Up Autism Myths and Misconceptions PR Newswire (Press Release)14:03 26-Aug-24
The Zacks Analyst Blog Costco, Merck & Co., Linde, Hamilton Beach Brands and Armanino Foods of Distinction Zacks14:01 26-Aug-24
Merck Receives European Commission Approval for WINREVAIR™ (sotatercept) in Combination With… Business Wire (Press Release)11:49 26-Aug-24
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting Pd-1 Drugs For … Benzinga19:17 23-Aug-24
Fierce Pharma Asia—J&J's Tagrisso challenger; Merck's revised Kelun deal; The next biosecurity… FiercePharma15:15 23-Aug-24
Merck (MRK) Falls 10% in 3 Months: Should You Buy the Dip? Zacks14:36 23-Aug-24
Biopharmaceuticals Global Business Report 2024 with Focus on 200+ Select Players Including Abbott, Amgen, Biogen, Eli… GlobeNewswire (Press Release)12:27 23-Aug-24
Senator, Dr. Rasha Kelej focuses on Breaking Infertility Stigma in the Tenth Episode of “Our… African Press Organization11:52 23-Aug-24
FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and… FiercePharma20:46 22-Aug-24
Merck's Ebola Vaccine Showed 84% Effectiveness During Large Outbreak In Africa Benzinga14:44 22-Aug-24
Senator, Dr. Rasha Kelej focuses on “Stopping Gender Based Violence” in the Ninth Episode of… African Press Organization13:39 22-Aug-24
Merck to Gain Investigational Bispecific Antibody in $1.3 Billion Curon Biopharmaceutical Deal PharmTech.com13:37 22-Aug-24
Merck Ebola vaccine Ervebo shown to offer substantial protection STAT18:52 21-Aug-24
Dimethyl Carbonate Market Forecast Report 2024-2034, with Profiles of UBE, LOTTE Chemical Corporation, Tokyo Chemical… GlobeNewswire (Press Release)14:55 21-Aug-24
Senator, Dr. Rasha Kelej focuses on Sustainability being a Shared Responsibility in the Eighth… African Press Organization14:45 21-Aug-24
First real-world analysis of Merck's Ebola vaccine reveals 84% efficacy during DRC outbreak FiercePharma12:50 21-Aug-24
Merck & Co. Drops Kelun Claudin 18.2 ADC But Exercises Bispecific Option Scrip Pharma Intelligence09:08 21-Aug-24
Merck Biopharma's Bavencio changes urothelial carcinoma treatment paradigm in Korea Korea Biomedical Review06:01 21-Aug-24
Should Weakness in Merck & Co., Inc.'s (NYSE:MRK) Stock Be Seen As A Sign That Market Will Correct The Share Price… Simply Wall St19:47 20-Aug-24
Merck's reduced dose of hybrids goes down easily International Financing Review16:27 20-Aug-24
PRICED: Merck KGaA EUR800m 30NC5.25 hybrid International Financing Review15:16 20-Aug-24
Merck KGaA prices EUR800m 30NC5.25 hybrid International Financing Review15:16 20-Aug-24
Winrevair From Merck Pharmacy Times15:00 20-Aug-24
Allocs out for Merck KGaA EUR800m 30NC5.25 hybrid International Financing Review14:35 20-Aug-24
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering… FierceBiotech12:52 20-Aug-24
Merck KGaA 30NC5.25 hybrid final terms: EUR800m at 4% International Financing Review12:32 20-Aug-24
Merck exercises option on one Kelun ADC, returns another as it tweaks broad deal ENDPOINTS12:19 20-Aug-24
Books for Merck KGaA 30NC5.25 hybrid over EUR5.2bn, guidance out, size set - UPDATE International Financing Review11:52 20-Aug-24
Books for Merck KGaA 30NC5.25 hybrid over EUR5bn, guidance out, size set International Financing Review11:41 20-Aug-24
Merck KGaA mandates EUR 30NC5.25 hybrid benchmark, tbp today International Financing Review08:18 20-Aug-24
Merck & Co's Options: A Look at What the Big Money is Thinking Benzinga21:20 19-Aug-24
Biopharmaceutical Excipients Focused Market Insights 2024-2029 Featuring Key Vendors - Merck, BASF, Avantor, Evonik… GlobeNewswire (Press Release)09:53 19-Aug-24
Fierce Pharma Asia—Merck-Curon bispecific deal; Legend's path forward; Missing adverse events… FiercePharma14:07 16-Aug-24
U.S. Companion Animal Health Market Size, Share & Trends Analysis Report 2024-2030 Featuring Major Players -… GlobeNewswire (Press Release)12:48 16-Aug-24
Bio Ketones Market Forecasts from 2024 to 2029 Featuring Bio Brands, Caldic, Eastman Chemical, Fitz Chem, Genomatica,… GlobeNewswire (Press Release)12:28 16-Aug-24
From foldables to AR headsets, OLED poised for solid growth, says Merck's Johannes Canisius Korea JoongAng Daily10:23 16-Aug-24
Merck signs MoU with Indian CDMO; Scorpius delays public offering ENDPOINTS15:27 15-Aug-24
Is Merck KGaA's (ETR:MRK) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? Simply Wall St09:41 15-Aug-24
NSG BioLabs and Merck collaborate to support biotech startups to advance research & innovations BioSpectrum Asia04:36 15-Aug-24
NSG BioLabs and Merck Collaborates to Support Biotech Start-ups to Advance Research & Innovations AsiaOne04:05 15-Aug-24
Senator, Dr. Rasha Kelej and Mrs. Neo Masisi Join Hands to Underscore Merck Foundation… African Press Organization16:06 14-Aug-24
Merck shows off flexible OLED displays at K-Display 2024 Korea JoongAng Daily11:02 14-Aug-24
Merck boasts materials know-how at K-Display The Korea Herald08:04 14-Aug-24
Merck: Buy This Bargain Before It's Gone Seeking Alpha08:28 13-Aug-24
Merck Discontinues Study Evaluating Vibostolimab/Pembrolizumab Combination for SCLC Pharmacy Times21:25 12-Aug-24
Merck (MRK) to Buy Curon's Bispecific Antibody Drug for $1.3B Zacks16:33 12-Aug-24
Senator, Dr. Rasha Kelej focuses on Coronavirus Health in the Seventh Episode of “Our Africa by … African Press Organization16:04 12-Aug-24
Merck to acquire Curon Biopharmaceutical’s B-Cell Depletion Therapy Pharmafile13:35 12-Aug-24
Life Science Tools and Reagents Market Report 2024, with Profiles of BD, Bio-Rad Laboratories, Danaher, F. Hoffmann-La… GlobeNewswire (Press Release)10:16 12-Aug-24
Merck acquires $700m clinical-stage bispecific antibody from Curon Biopharmaceutical Manufacturing Chemist09:34 12-Aug-24
Merck Animal Health Awards $20,000 In Scholarships To Future Bovine Veterinarians AgriMarketing08:06 12-Aug-24
Court of Appeals upholds dismissal of Merck MMR vaccine lawsuit Skeptical Raptor21:01 11-Aug-24
Week In Review: Curon Out-Licenses T-Cell-Engager To Merck For $700 Million Upfront Seeking Alpha11:03 11-Aug-24
Merck Life Science ties up with Aragen The Times of India00:33 10-Aug-24
Merck To Buy Autoimmune Treatment Drug For Up To $1.3B Law36020:50 9-Aug-24
Merck's $1.3B Deal For Potential Autoimmune Disorder Candidate Is Relevant To Cullinan's Investigational Drug, Says… Benzinga20:24 9-Aug-24
Merck Steps Into CD19 Bispecific Antibody Ring With Curon Deal Scrip Pharma Intelligence20:15 9-Aug-24
Merck buys B-cell therapy drug from Curon Biopharmaceutical for $700 million Vator19:43 9-Aug-24
Merck buys investigational B-cell depletion therapy from Chinese startup Curon Biopharma for $700 M BioSpectrum Asia17:54 9-Aug-24
Merck Life Science partners with Aragen to boost biotech R&D in India The Business Standard15:30 9-Aug-24
Merck pays $700M for bispecific, spying autoimmune opening and chance to challenge Amgen in… FierceBiotech14:04 9-Aug-24
Merck to buy drug targeting B-cell diseases for up to $1.3bn ShareCast13:42 9-Aug-24

      
            
      
    view more headlines
   
      
      
      
8 Sept 16:45
   
Don't miss out! Get the day's top headlines delivered to your inbox